Nerviano Medical Sciences Announces Licensing of Linker-Payload Technology to Solve Therapeutics to Develop and Commercialize Novel Antibody-Drug Conjugates.
The Connection Between Your Heart and Kidneys
The American Cancer Society and Color Health Announce Partnership Aimed at Increasing Access and Adherence to Cancer Screening and Prevention for U.S. Employers and Unions
The Doctors Company Names Christa Steele, MBA, to Board of Governors
The Netherlands is Europe’s Connected Life Sciences & Health Metropolis
America’s Best Wings: Everything You Need to Know
“We want the look at home hospitalization to change”
In Abidjan, to poor men, impossible love
Kidney transplant: AI to correct erroneous rejection diagnoses
Why do I need to get rid of dental plaque?
The Prévifrance mutual insurance company shows its good health and continues to conquer policyholders
NERVIANO, Italy, June 5, 2023 /PRNewswire/ — Nerviano Medical Sciences S.r.l. (NMS), a clinical-stage biotechnology company member of NMS Group S.p.A. (NMS group), the largest cancer...